Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in VYGR — Voyager Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$158,357
-$256,326 QoQ
Shares Held
45,245
-57.9% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 135 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. VYGR ranks #292 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in VYGR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $158,357 45,245
2026-03-31 $414,683 107,431
2025-12-31 $692,059 176,097
2025-09-30 $1,996,096 427,430
2025-06-30 $1,792,858 576,482
2025-03-31 $2,299,332 680,276
2024-12-31 $106,436 18,772
2024-09-30 $3,109,608 531,557
2024-06-30 $5,131,690 648,760
2024-03-31 $3,299,863 354,443
2023-12-31 $65,003 7,702
2023-09-30 $1,084,201 139,897
2023-06-30 $314,897 27,502
2023-03-31 $367,218 47,629
2022-12-31 $99,118 16,249
2022-09-30 $78,231 13,215
2022-06-30 $232,793 39,390
2022-03-31 $669,545 87,867
2021-12-31 $33,063 12,201
2021-09-30 $94,443 35,910
2021-06-30 $123,470 29,896
2021-03-31 $104,825 22,256
2020-12-31 $95,565 13,366
2020-09-30 $439,057 41,149
2020-06-30 $283,960 22,501
2020-03-31 $338,465 36,991